Corporate Board Profile
Tech Score: 50/100
4 mention(s) identify SIMON H. STERTZER, M.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| BioCardia, Inc. | 2020-12-02 | He has served as a Director of Frontiere Algorithmic Design LLC, a software development company, from June 2014. | Dr. Stertzer serves as Director of Frontiere Algorithmic Design LLC, a software development company, indicating involvement with software development. |
| BioCardia, Inc. | 2022-04-27 | Dr. Stertzer serves on the medical advisory board of Avenda Health, a private prostate cancer therapy company, and was appointed in June 2019. Dr. Stertzer is managing member of Windrock Enterprises, LLC, a real estate investment company, since May 1999. He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company that went public in 1996 and was subsequently acquired by Medtronic. He also serves as Director of AVIA App LLC since 2015. | Served as Director of software development companies and has operational experience in technology companies; holds a medical degree but also has direct involvement with software companies. |
| BioCardia, Inc. | 2023-09-01 | He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering... He also serves as Director of AVIA App LLC since 2015. | Dr. Stertzer has served as director of software development companies and has operational experience with software companies, indicating relevant software-related technical skills. |
| BioCardia, Inc. | 2024-04-15 | Dr. Stertzer serves on the medical advisory board of Avenda Health, a private prostate cancer therapy company, and was appointed in June 2019. Dr. Stertzer is managing member of Windrock Enterprises, LLC, a real estate investment company since May 1999. He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company that went public in 1996 and was subsequently acquired by Medtronic. He also serves as Director of AVIA App LLC since 2015. | Dr. Stertzer has served as director of software development companies and has been involved with software companies, indicating technical skills related to software. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-28 | Dr. Stertzer received his Doctor of Medicine degree from New York University. He also earned a Certificat de Physiologie from University of Paris (Sorbonne) and had a fellowship at New York University Hospital in Cardiovascular Disease. |
| 2018-04-27 | Dr. Stertzer received his Doctor of Medicine degree from New York University. He also earned a Certificat de Physiologie from University of Paris (Sorbonne) and had a fellowship at New York University Hospital in Cardiovascular Disease. Dr. Stertzer received a Bachelor of Arts degree in Humanities from Union College. |
| 2019-10-15 | Dr. Stertzer received his Doctor of Medicine degree from New York University. He also earned a Certificat de Physiologie from University of Paris (Sorbonne) and had a fellowship at New York University Hospital in Cardiovascular Disease. |
| 2020-12-02 | He has served as a Director of Frontiere Algorithmic Design LLC, a software development company, from June 2014. |
| 2021-04-30 | Dr. Stertzer has served as a Director of Frontiere Algorithmic Design LLC, a software development company, from June 2014. Dr. Stertzer received his Doctor of Medicine degree from New York University. |
| 2022-04-27 | Dr. Stertzer serves on the medical advisory board of Avenda Health, a private prostate cancer therapy company, and was appointed in June 2019. Dr. Stertzer is managing member of Windrock Enterprises, LLC, a real estate investment company, since May 1999. He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company that went public in 1996 and was subsequently acquired by Medtronic. He also serves as Director of AVIA App LLC since 2015. |
| 2023-09-01 | He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering... He also serves as Director of AVIA App LLC since 2015. |
| 2024-04-15 | Dr. Stertzer serves on the medical advisory board of Avenda Health, a private prostate cancer therapy company, and was appointed in June 2019. Dr. Stertzer is managing member of Windrock Enterprises, LLC, a real estate investment company since May 1999. He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company that went public in 1996 and was subsequently acquired by Medtronic. He also serves as Director of AVIA App LLC since 2015. |
Data sourced from SEC filings. Last updated: 2025-10-11